Results 111 to 120 of about 17,658 (183)

Efficacy of a single dose switch from aflibercept to ranibizumab in the treatment of neovascular age-related macular degeneration. [PDF]

PLoS One
Iby J, Coulibaly L, Hollaus M, Yeghiazaryan L, Schmidt-Erfurth U, Bühl W, Sacu S.   +6 more
europepmc   +1 more source

Short-term efficacy of aflibercept 8 mg in refractory neovascular age-related macular degeneration: a retrospective case series from Taiwan. [PDF]

BMC Ophthalmol
Chi SC, Hwang DK, Chen SJ, Weng CC, Huang YM, Chou YB, Lin TC.   +6 more
europepmc   +1 more source

Visual and Anatomic Outcomes of Faricimab in Naïve Neovascular Age-Related Macular Degeneration with Subretinal Hemorrhage: A Multi-Centre Retrospective Analysis. [PDF]

Clin Ophthalmol
Sivachandran N, Ji PX, Khan H, Pickel L, Mojumder O, Aziz AA, Khan H, Sulahria H, Gahn GM, Khanani AM.   +9 more
europepmc   +1 more source

PANoptosis-Related Diagnostic Biomarkers in Non-Neovascular Age-Related Macular Degeneration: An Integrative Transcriptomic and Experimental Study. [PDF]

Genet Res (Camb)
Li J, Ma Y, Hu M, Zhang Q, Wang A, Tang Q, Guo Q, Huang B.   +7 more
europepmc   +1 more source

Evaluating the risk of recurrence in neovascular age-related macular degeneration using OCT-angiography at the time of treatment exit. [PDF]

Br J Ophthalmol
Jaggi D, Marugg S, Berger LE, Munk MR, Zinkernagel MS, Heussen FM.   +5 more
europepmc   +1 more source

Targeted Fluorescence Imaging of Bevacizumab-800CW in Patients with Neovascular Age-Related Macular Degeneration. [PDF]

J Nucl Med
Schmidt I, Volkmer P, Müskens RPHM, van der Waaij AM, van Dam GM, Huiskamp EA, Nagengast WB.   +6 more
europepmc   +1 more source

Reducing the Carbon Footprint of Neovascular Age-Related Macular Degeneration Therapy: Environmental Impact of Transitioning to Aflibercept 8 mg. [PDF]

J Ophthalmol
Veritti D, Misciagna M, Teatino C, Pontoni C, Blasutig M, Kuftic M, Pece S, Morsanutto A, Pece A, Lanzetta P.   +9 more
europepmc   +1 more source

Beyond Cost: Faricimab as a Driver of Service Efficiency and Quality in Neovascular Age-Related Macular Degeneration Care. [PDF]

Ophthalmol Ther
Gil-Rojas Y, Nicholson L, Eymere S, Cox O, Bagijn M.   +4 more
europepmc   +1 more source

Long-Term Follow-Up of Faricimab Intravitreal Injections in Naïve Neovascular Age-Related Macular Degeneration.

Ophthalmic Res
Belloni Baroni L, Toto L, Formenti F, Passamonti M, Quarta A, Ruggeri ML, Aloia R, Di Nicola M, Mastropasqua R.   +8 more
europepmc   +1 more source

Outer Retinal Hyperreflective Foci as a Predictor of Hyperreflective Material Boundary Remodeling and Visual Outcomes in Neovascular Age-Related Macular Degeneration. [PDF]

Medicina (Kaunas)
Jovanović M, Milošević J, Carrasco Guijarro M, Jovanović S, Todorović D, Petrović N, Paunović S, Janićijević K, Živković MLJ.   +8 more
europepmc   +1 more source